Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?

Authors: Gutiérrez-Larrañaga M, González-López E, Roa-Bautista A, Rodrigues PM, Díaz-González Á, Banales JM, López-Hoyos M, Santos-Laso A, Crespo J.
Liver Cancer. 2021 Sep 21;10(6):545-560. doi: 10.1159/000518104. eCollection 2021 Nov. PubMed: 34950178
Mostrar Más
PMID: 34950178
Title: Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?
Authors: Gutiérrez-Larrañaga M, González-López E, Roa-Bautista A, Rodrigues PM, Díaz-González Á, Banales JM, López-Hoyos M, Santos-Laso A, Crespo J.
Citation: Liver Cancer. 2021 Sep 21;10(6):545-560. doi: 10.1159/000518104. eCollection 2021 Nov.
First Author: Gutiérrez-Larrañaga M
Journal/Book: Liver Cancer
Publication Year: 2021
Create Date: 2021/12/24
PMCID: PMC8647071
NIHMS ID:
DOI: 10.1159/000518104